Skip to content
Home/Companies/Biotech/Formycon
FO

Formycon

Biotech·Germany·Active·4yr hold

Formycon is a biotech company, headquartered in Germany.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Formycon?

Formycon is currently owned by Athos through Athos Evergreen Life Sciences (2001 vintage), since 2022.

Hand-verified · updated 2026-07-03

Athos
Investor
Athos
Athos Evergreen Life Sciences · 2001 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusActive

More from Athos Evergreen Life Sciences

Other portfolio companies in the same fund.

Doctolib
Active
FintechFrance· 2026
AAVantgarde Bio
Active
BiotechItaly· 2025
AMSilk
Active
BiotechGermany· 2025
Antheia
Active
BiotechUnited States· 2025
Bambusa Therapeutics
Active
BiotechUnited States· 2025
NexWafe
Active
EnergyGermany· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings